TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building. May 12, 2006
TCL Archive Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease June 29, 2012
TCL Archive In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations May 28, 1993
